Francisco Bori

Pharmacist working in the Chilean Public Health Institute (ISP). Specialist in the evaluation for marketing authorization of biological product. Experience in reviewing the CMC sections of registration dossiers for a variety of biopharmaceuticals, including vaccines, blood related products, and biotechnology-derived drugs. Currently specializing in the process of review CMC and regulation of advanced therapy medicinal products (ATMPs), including participation in regional and international forums. Holds a diploma in regulatory affairs from the University of Chile, with a proactive and collaborative approach to regulatory science. Previous experience includes clinical pharmacy practice in hospital settings. Participated in global and regional events such as the WHO workshop on regulatory frameworks for human cells, tissues, and ATMPs (Muscat, Oman), and the X Latin American Symposium on Cell Culture Technology (Viña del Mar, Chile)